mRNA vaccine
Clinical trials for mRNA vaccine explained in plain language.
Never miss a new study
Get alerted when new mRNA vaccine trials appear
Sign up with your email to follow new studies for mRNA vaccine, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
MRNA vaccine aims to prevent shingles in older adults
Vaccine Recruiting nowThis study is testing a new mRNA vaccine to prevent shingles (herpes zoster) in adults aged 40 and older. The vaccine uses mRNA technology, similar to some COVID-19 vaccines, and is freeze-dried for easier storage. Researchers will compare different doses against existing vaccine…
Matched conditions: MRNA VACCINE
Phase 1/2 • Sponsor: Sinovac Biotech Co., Ltd • Aim: Vaccine
Last updated Jun 27, 2026 09:04 UTC
-
Personalized mRNA vaccine aims to train immune system against ovarian cancer
Disease control Recruiting nowThis trial tests a personalized mRNA vaccine called NeoOVIV in people with stage II or III ovarian cancer who have had surgery. The vaccine is designed to teach the immune system to recognize and attack cancer cells. Participants receive the vaccine alongside standard chemotherap…
Matched conditions: MRNA VACCINE
Phase 1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can a custom mRNA vaccine keep ovarian cancer from coming back?
Disease control Recruiting nowThis early-phase trial is testing whether a personalized mRNA vaccine called NeoOVSV, given alongside standard chemotherapy and an immunotherapy drug, can safely help prevent ovarian cancer from returning after surgery. The vaccine is designed to train the immune system to recogn…
Matched conditions: MRNA VACCINE
Phase 1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New mRNA treatment targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new mRNA-based treatment for people with advanced solid tumors that have not responded to standard therapies. The treatment aims to control tumor growth by delivering a specific protein (IL-22BP) using a peptide carrier. The main goals are to check …
Matched conditions: MRNA VACCINE
Phase 1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
MRNA vaccine takes on Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early study tests a new mRNA vaccine (IL-22BP) for people with advanced solid tumors like sarcoma, head and neck cancer, or melanoma that have not responded to standard treatments. The vaccine is injected directly into tumors. Only 6 participants are enrolled to check safety…
Matched conditions: MRNA VACCINE
Phase 1 • Sponsor: Xingchen Peng • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC